Certified as a medical product, Cellular Matrix BCT-HA® is a unique and patented technology that makes it possible to safely create a cell-friendly PRP-HA network in a closed system that preserves both the platelets and the plasma components.
Cellular Matrix BCT-HA® tubes make it possible to process autologous platelet-rich plasma (Regen PRP) combined with uncured hyaluronic acid (HA) in a closed system.
With its unique capacity for holding water, hyaluronic acid is a key molecule involved in skin moisture.
Platelet concentrates processed with RegenLab technology offer an autologous reservoir of growth factors.
Platelets are crucial to the mechanisms of tissue repair. They deliver essential growth factors, such as FGF, PDGF, TGF-β, EGF, VEGF and IGF, which participate in the migration, differentiation and proliferation of stem cells. Thrombocytes also stimulate fibroblasts and endothelial cells, thus inducing the fortification of a new extracellular matrix and neovascularisation. The thrombocytes are concentrated from the patient's own blood.